1. Home
  2. WVE vs WLKP Comparison

WVE vs WLKP Comparison

Compare WVE & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • WLKP
  • Stock Information
  • Founded
  • WVE 2012
  • WLKP 2014
  • Country
  • WVE Singapore
  • WLKP United States
  • Employees
  • WVE N/A
  • WLKP N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • WLKP Major Chemicals
  • Sector
  • WVE Health Care
  • WLKP Industrials
  • Exchange
  • WVE Nasdaq
  • WLKP Nasdaq
  • Market Cap
  • WVE 915.6M
  • WLKP 778.4M
  • IPO Year
  • WVE 2015
  • WLKP 2014
  • Fundamental
  • Price
  • WVE $8.29
  • WLKP $21.87
  • Analyst Decision
  • WVE Strong Buy
  • WLKP
  • Analyst Count
  • WVE 17
  • WLKP 0
  • Target Price
  • WVE $19.94
  • WLKP N/A
  • AVG Volume (30 Days)
  • WVE 2.2M
  • WLKP 34.5K
  • Earning Date
  • WVE 07-30-2025
  • WLKP 11-04-2025
  • Dividend Yield
  • WVE N/A
  • WLKP 8.61%
  • EPS Growth
  • WVE N/A
  • WLKP N/A
  • EPS
  • WVE N/A
  • WLKP 1.49
  • Revenue
  • WVE $93,946,000.00
  • WLKP $1,101,803,000.00
  • Revenue This Year
  • WVE N/A
  • WLKP $8.90
  • Revenue Next Year
  • WVE $10.02
  • WLKP $6.87
  • P/E Ratio
  • WVE N/A
  • WLKP $14.65
  • Revenue Growth
  • WVE N/A
  • WLKP N/A
  • 52 Week Low
  • WVE $5.04
  • WLKP $21.19
  • 52 Week High
  • WVE $16.74
  • WLKP $25.04
  • Technical
  • Relative Strength Index (RSI)
  • WVE 41.39
  • WLKP 44.08
  • Support Level
  • WVE $7.12
  • WLKP $21.99
  • Resistance Level
  • WVE $10.45
  • WLKP $22.41
  • Average True Range (ATR)
  • WVE 0.54
  • WLKP 0.25
  • MACD
  • WVE -0.24
  • WLKP -0.02
  • Stochastic Oscillator
  • WVE 33.82
  • WLKP 16.85

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests

Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.

Share on Social Networks: